key: cord-0760644-dhftbrp6 authors: Saberi, Hooshang; Tanha, Rastegar Rahmani; Derakhshanrad, Nazi; Soltaninejad, Mohammad Javad title: Acute Presentation of Third Ventricular Cavernous Malformation following COVID-19 Infection in a Pregnant Woman: A Case Report date: 2021-03-23 journal: Neurochirurgie DOI: 10.1016/j.neuchi.2021.03.010 sha: 40b9e34899422e788af881dde0e8c9d4fdfd72f4 doc_id: 760644 cord_uid: dhftbrp6 Background: Cerebral cavernous malformation (CCM) in third ventricular area may become symptomatic relatively rarely, secondary to hemorrhage and growth or rupture into the ventricle, causing obstructive hydrocephalus, during third trimester of pregnancy. Case Description: A 34+4 weeks pregnant (G4P1A2) lady was admitted to one of our satellite hospitals with one-week history of severe headache, blurred vision, nausea, vomiting, and right-sided facial numbness. At presentation she had sudden decreased level of consciousness with Glasgow Coma Scale (GCS) equal to 4, and bilateral fixed pupils. A brain computed tomography (CT) showed enlargement of both lateral ventricles with 2.5 cm sized round hemorrhagic lesion at the right posterior thalamic region. After medical stabilization and placement of an external ventricular drain (EVD), the patient was referred for neurosurgical intervention. Magnetic resonance imaging (MRI) revealed a cavernous hemangioma adjacent to the right posterior wall of the third ventricle. After cesarean section and anterior interhemispheric trans-callosal approach, the mass was removed totally. However, on third postoperative day, she experienced mild hypoxia and dyspnea with fever. Chest CT-scan of the patient showed bilateral consolidation. Thereafter, COVID-19 was confirmed subsequently with positive nasopharyngeal swab testing for RT-PCR. The patient was treated as COVID-19 infection and symptoms improved on day 10 of the treatment and completely recovered. Conclusions: COVID-19 may promote ICH from CCM leading to obstructive hydrocephalous in our patient. sided facial numbness. At presentation she had sudden decreased level of consciousness with Glasgow Coma Scale (GCS) equal to 4, and bilateral fixed pupils. A brain computed tomography (CT) showed enlargement of both lateral ventricles with 2.5 cm sized round hemorrhagic lesion at the right posterior thalamic region. After medical stabilization and placement of an external ventricular drain (EVD), the patient was referred for neurosurgical intervention. Magnetic resonance imaging (MRI) revealed a cavernous hemangioma adjacent to the right posterior wall of the third ventricle. After cesarean section and anterior interhemispheric trans-callosal approach, the mass was removed totally. However, on third postoperative day, she experienced mild hypoxia and dyspnea with fever. Chest CT-scan of the patient showed bilateral consolidation. Thereafter, COVID-19 was confirmed subsequently with positive nasopharyngeal swab testing for RT-PCR. The patient was treated as COVID-19 infection and symptoms improved on day 10 of the treatment and completely recovered. Conclusions: COVID-19 may promote ICH from CCM leading to obstructive hydrocephalous in our patient. J o u r n a l P r e -p r o o f 3 Cavernous malformations (CM) around the third ventricle may become symptomatic secondary to hemorrhage and growth or rupture into the ventricle, causing hydrocephalus [1] . To date, rare cases of obstructive hydrocephalus due to cerebral cavernous malformations (CCM) have been reported in pregnancy. Here, we present a case of young pregnant woman with acute obstructive hydrocephalus associated with confirmed coronavirus disease 2019 (COVID- A 29-year-old 34 +4 weeks pregnant (G4P1A2), right-handed female without significant past medical history such as hypertension, diabetes, heart disease, and malignancy was admitted to a satellite referring hospital in our region with one-week history of severe headache, blurred vision, nausea, vomiting, and right-sided facial numbness. At presentation she had sudden decreased level of consciousness with Glasgow Coma Scale (GCS) equal to 4 and bilateral fixed pupils due to acute hydrocephalus treated with external ventricular drain (EVD) elsewhere. The EVD had been placed urgently with resolution of hydrocephalus and improvement of level of consciousness (GCS=14). She had no history of central nervous system (CNS) infection or trauma. At her admission in our center, fundoscopic examination revealed bilateral papilledema. A brain computed tomography (CT) showed enlargement of both lateral ventricles with 2.5 cm sized round hemorrhagic lesion at the right thalamomesencephalic region. On examination, the patient was drowsy and neurological examination showed left-sided moderate hemiparesis (3/5) and hemisensory loss, and sensory deficit on the right side of the face. Preoperative blood pressure (BP) was 120/70 mm Hg, heart rate (HR) was 88 bpm, Page 4 of 11 J o u r n a l P r e -p r o o f 4 respiratory rate (RR) was 18, oxygen saturation was 96% and axial body temperature = 37 °C without any history of drug reaction and fever. On laboratory tests, there were leukocytosis with white blood cells (WBCs) counts equal 15600 per mm 3 , lymphopenia with 6.6% lymphocyte and mild elevation of the C-reactive protein (CRP), equal to 7 mg/l. Regarding the COVID-19 pandemic, to rule out corona infection, RT-PCR test of nasal swab was requested. Three-Tesla cerebral magnetic resonance imaging (MRI) revealed a single lesion measuring 2.5 cm × 2.0 cm × 1.5 cm at the right posterior thalamic region and adjacent to the right side of third ventricle wall with endophytic growth into the 3rd ventricle, causing obstructive hydrocephalus. Cerebral CT angiogram revealed no vascular abnormalities [ Figure 1A , B, C]. The patient was finally diagnosed with intracranial space-occupying lesion and cavernous hemangioma. The patient provided written informed consent for pregnancy termination and neurological surgery at the 36th week of gestation, because of previous history of cesarean section in the second pregnancy. Interdisciplinary approach by the neurosurgeons, obstetricians and anesthetist is pivotal for delicate care of the patient and the baby. In this patient because of the COVID-19 pandemic, for decreasing aerosolization as protocols [2] , general anesthesia with rapid sequence induction was performed. Delivery was uneventful and the infant girl weighing 2400 g was born healthy. After setting up the stereotactic neuronavigation system, through a planned horseshoe-shaped incision and craniotomy in the right frontal parasagittal region, performed by placing burr holes on both sides of the superior sagittal sinus. Durotomy was done, and the dural flaps were reflected medially up towards the superior sagittal sinus. Anterior interhemispheric trans-callosal approach was performed for removing the deep lesion. The lateral ventricle was entered after 4.7% lymphocyte), moderate elevation of the CRP (55mg/l), high serum lactate level=48 mg/dl, and lumbar CSF analysis revealed WBCs=5 cells/µL, Lactate dehydrogenase=15.6, protein=49.9 mg/dL, glucose=56 mg/dL. Chest CT-scan of the patient showed bilateral patchy consolidation with air-bronchogram in the lower lobes, multiple bilateral patchy ground-glass opacities, and bilateral pleural effusion [ Figure 3 ]. Thereafter, COVID-19 was confirmed subsequently with positive testing for real-time polymerase chain reaction (RT-PCR) from a nasopharyngeal swab and the patient was admitted to the pulmonary ICU for COVID-19 patients. The patient was treated as COVID-19 pneumonia by atazanavir capsules 300 mg/po/daily, azithromycin 500mg tablets/po/daily, and supportive care, including oxygen therapy with a highconcentration mask with reservoir bag (10L/min), and respiratory physiotherapy. The symptoms improved on day 10 of the treatment. She remained in good health after completing her treatment course until she was discharged three weeks after the admission. Just post-operative brain CT scan and six month follow-up brain MRI showed gross total resection of the CCM [ Figure 1D , E respectively] and complete clinical recovery was observed. Overall, estimates of the hemorrhage risk of CM is 0.7% to 6% per year, according to variety of risk factors such as; prior CM bleeding, family history of CM, causative CM gene [3] , and infratentorial location [4] . While age, sex, size, multiplicity, and associated developmental venous anomalies are not risk factors for CM bleeding [5] . Therefore, we recommend that all pregnant women with a diagnosis of a CCM should be referred to a neurosurgeon and evaluated on aforementioned risk of hemorrhage. Given that, our patient had none of these risk factors for hemorrhage of CCM and also had asymptomatic cavernoma in three previous pregnancies, we hypothesize that COVID-19 may In addition, patients with atypical presentations of COVID-19 may be unaware of their illness especially during the incubation period. Some patients diagnosed with COVID-19 have exhibited only neurological symptoms as the initial symptoms, such as; headache, languidness, unstable walking, malaise, cerebral infarction, cerebral hemorrhage and other neurological signs. In a recent study, 36.4% of patients with COVID-19 had neurological manifestations: CNS (24.8%), peripheral nervous system (PNS) (8.9%), and skeletal muscle injury (10.7%). In patients with CNS manifestations, the most common reported symptoms were dizziness, headache, impaired consciousness, and acute cerebrovascular diseases. In patients with PNS symptoms, the most common reported symptoms was taste impairment associated with smell impairment. [8] More severe neurological complications of COVID-19 have also been recently reported, including acute hemorrhagic necrotizing encephalopathy [9] , ischemic stroke from large-vessel occlusion, acute transverse myelitis , Guillain Barré syndrome [10] , meningitis [11] , reversible cranial nerve injuries (Miller Fisher syndrome) [12] , polyneuropathy, and cerebral vasculitis/endotheliitis [6] . The endotheliopathy due to direct endothelial infection with SARS-COV-2 and the indirect damage caused by lymphocytic infiltration play the predominant role in the development of COVID-19-associated coagulopathy as found in our pathologic specimen [13] . Currently, although there have been many cases of patients with COVID-19 complicated by cerebral hemorrhages such as our case [14] . Hence, the physiological relationship between COVID-19 and the incidence of cerebral hemorrhage is related to thrombangitis pathology [6, 13] . De novo obstructive (non-communicating) hydrocephalus developing during pregnancy is a rarely reported event. Etiology is diverse as infectious (bacterial, viral), CNS malformations, head traumas, tumors, and hemorrhage [15] . Based on these several lines of evidence, we hypothesize that COVID-19 may have precipitated ICH from CCM, followed by obstructive hydrocephalus in our patient. Conclusions: COVID-19 may have precipitated ICH from CCM, followed by obstructive hydrocephalous, in our patient. Cavernous Malformations in and Around the Third Ventricle: Indications, Approaches, and Outcomes Consensus guidelines for managing the airway in patients with COVID-19: Guidelines from the Difficult Airway Society, the Association of Anaesthetists the Intensive Care Society, the Faculty of Intensive Care Medicine and the Royal College of Anaesthetists Cerebral cavernous malformations and pregnancy: hemorrhage risk and influence on obstetrical management Symptomatic hemorrhage from cerebral cavernous malformations: evidence from a cohort study Hemorrhage from cerebral cavernous malformations: a systematic pooled analysis COVID-19 neurologic complication with CNS vasculitis-like pattern Acute cerebrovascular disease following COVID-19: a single center, retrospective, observational study Neurological manifestations of hospitalized patients with COVID-19 in Wuhan, China: a retrospective case series study COVID-19-associated acute hemorrhagic necrotizing encephalopathy: CT and MRI features Guillain-Barré syndrome associated with SARS-CoV-2 infection: causality or coincidence? A first case of meningitis/encephalitis associated with SARS-Coronavirus-2 Miller Fisher Syndrome and polyneuritis cranialis in COVID-19 The coagulopathy, endotheliopathy, and vasculitis of COVID-19 Potential neurological symptoms of COVID-19 Management of obstructive hydrocephalus in pregnant patient